Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-20-043795
Filing Date
2020-12-21
Accepted
2020-12-21 16:06:21
Documents
5
Effectiveness Date
2020-12-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea131489-defa14a_citiuspharm.htm DEFA14A 18170
2 GRAPHIC proxy_001.jpg GRAPHIC 340010
3 GRAPHIC proxy_002.jpg GRAPHIC 462967
4 GRAPHIC proxy_003.jpg GRAPHIC 186768
5 GRAPHIC proxy_004.jpg GRAPHIC 157940
  Complete submission text file 0001213900-20-043795.txt   1600227
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-38174 | Film No.: 201404422
SIC: 2834 Pharmaceutical Preparations